Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05327530
Title A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley)
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors EMD Serono Research & Development Institute, Inc.
Indications

transitional cell carcinoma

Therapies

Avelumab

Avelumab + NKTR-255

Avelumab + Sacituzumab govitecan-hziy

Avelumab + M6223

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.